European Heart Journal
عامل التأثير - التحليلات · اتجاه · تصنيف · تصنيف


New

عامل التأثير

2019-2020

22.673

-8.9 %

عامل التأثير Trend

Related Journals

Popular Journals

European Heart Journal

The 2019-2020 عامل التأثير of European Heart Journal is 22.673, which is just updated in 2020.

European Heart Journal Impact Factor
Highest IF
24.889
Highest عامل التأثير

The highest عامل التأثير of European Heart Journal is 24.889.

Lowest IF
10.478
Lowest عامل التأثير

The lowest عامل التأثير of European Heart Journal is 10.478.

Total Growth Rate
116.4%
IF Total Growth Rate

The total growth rate of European Heart Journal IF is 116.4%.

Annual Growth Rate
12.9%
IF Annual Growth Rate

The annual growth rate of European Heart Journal IF is 12.9%.

عامل التأثير Ranking

Subcategory Quartile Rank Percentile
Cardiology and Cardiovascular Medicine Q1 3/324

Cardiology and Cardiovascular Medicine 99%

عامل التأثير Ranking

· In the Cardiology and Cardiovascular Medicine research field, the Quartile of European Heart Journal is Q1. European Heart Journal has been ranked #3 over 324 related journals in the Cardiology and Cardiovascular Medicine research category. The ranking percentile of European Heart Journal is around 99% in the field of Cardiology and Cardiovascular Medicine.

European Heart Journal Impact Factor 2020-2021 Prediction

European Heart Journal Impact Factor Predition System

European Heart Journal Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
46097
Total Citations
1338945

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

عامل التأثير History

Year عامل التأثير
Year عامل التأثير
2019-2020 22.673
2018-2019 24.889
2017-2018 23.425
2016-2017 20.212
2015-2016 15.064
2014-2015 15.203
2013-2014 14.723
2012-2013 14.097
2011-2012 10.478
عامل التأثير History

· The 2019-2020 عامل التأثير of European Heart Journal is 22.673
· The 2018-2019 عامل التأثير of European Heart Journal is 24.889
· The 2017-2018 عامل التأثير of European Heart Journal is 23.425
· The 2016-2017 عامل التأثير of European Heart Journal is 20.212
· The 2015-2016 عامل التأثير of European Heart Journal is 15.064
· The 2014-2015 عامل التأثير of European Heart Journal is 15.203
· The 2013-2014 عامل التأثير of European Heart Journal is 14.723
· The 2012-2013 عامل التأثير of European Heart Journal is 14.097
· The 2011-2012 عامل التأثير of European Heart Journal is 10.478

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1979 0 2
1980 89 12
1981 69 100
1982 133 197
1983 298 481
1984 306 657
1985 261 1105
1986 204 1300
1987 507 1690
1988 410 2198
1989 297 2682
1990 308 3088
1991 363 3436
1992 415 3843
1993 445 4048
1994 368 4313
1995 617 5348
1996 454 6641
1997 463 8051
1998 461 9987
1999 399 11293
2000 491 13757
2001 466 14696
2002 458 15747
2003 2987 18819
2004 531 21316
2005 704 27050
2006 889 33604
2007 754 39989
2008 798 47186
2009 569 54004
2010 706 60096
2011 630 68267
2012 744 78691
2013 4786 87831
2014 918 94592
2015 1012 96689
2016 1039 95036
2017 5012 97597
2018 5139 81964
2019 5265 91580
2020 5289 122071
2021 43 7891
Publications Cites Dataset

· The European Heart Journal has published 0 reports and received 2 citations in 1979.
· The European Heart Journal has published 89 reports and received 12 citations in 1980.
· The European Heart Journal has published 69 reports and received 100 citations in 1981.
· The European Heart Journal has published 133 reports and received 197 citations in 1982.
· The European Heart Journal has published 298 reports and received 481 citations in 1983.
· The European Heart Journal has published 306 reports and received 657 citations in 1984.
· The European Heart Journal has published 261 reports and received 1105 citations in 1985.
· The European Heart Journal has published 204 reports and received 1300 citations in 1986.
· The European Heart Journal has published 507 reports and received 1690 citations in 1987.
· The European Heart Journal has published 410 reports and received 2198 citations in 1988.
· The European Heart Journal has published 297 reports and received 2682 citations in 1989.
· The European Heart Journal has published 308 reports and received 3088 citations in 1990.
· The European Heart Journal has published 363 reports and received 3436 citations in 1991.
· The European Heart Journal has published 415 reports and received 3843 citations in 1992.
· The European Heart Journal has published 445 reports and received 4048 citations in 1993.
· The European Heart Journal has published 368 reports and received 4313 citations in 1994.
· The European Heart Journal has published 617 reports and received 5348 citations in 1995.
· The European Heart Journal has published 454 reports and received 6641 citations in 1996.
· The European Heart Journal has published 463 reports and received 8051 citations in 1997.
· The European Heart Journal has published 461 reports and received 9987 citations in 1998.
· The European Heart Journal has published 399 reports and received 11293 citations in 1999.
· The European Heart Journal has published 491 reports and received 13757 citations in 2000.
· The European Heart Journal has published 466 reports and received 14696 citations in 2001.
· The European Heart Journal has published 458 reports and received 15747 citations in 2002.
· The European Heart Journal has published 2987 reports and received 18819 citations in 2003.
· The European Heart Journal has published 531 reports and received 21316 citations in 2004.
· The European Heart Journal has published 704 reports and received 27050 citations in 2005.
· The European Heart Journal has published 889 reports and received 33604 citations in 2006.
· The European Heart Journal has published 754 reports and received 39989 citations in 2007.
· The European Heart Journal has published 798 reports and received 47186 citations in 2008.
· The European Heart Journal has published 569 reports and received 54004 citations in 2009.
· The European Heart Journal has published 706 reports and received 60096 citations in 2010.
· The European Heart Journal has published 630 reports and received 68267 citations in 2011.
· The European Heart Journal has published 744 reports and received 78691 citations in 2012.
· The European Heart Journal has published 4786 reports and received 87831 citations in 2013.
· The European Heart Journal has published 918 reports and received 94592 citations in 2014.
· The European Heart Journal has published 1012 reports and received 96689 citations in 2015.
· The European Heart Journal has published 1039 reports and received 95036 citations in 2016.
· The European Heart Journal has published 5012 reports and received 97597 citations in 2017.
· The European Heart Journal has published 5139 reports and received 81964 citations in 2018.
· The European Heart Journal has published 5265 reports and received 91580 citations in 2019.
· The European Heart Journal has published 5289 reports and received 122071 citations in 2020.
· The European Heart Journal has published 43 reports and received 7891 citations in 2021.
· The total publications of European Heart Journal is 46097.
· The total citations of European Heart Journal is 1338945.

European Heart Journal
Journal Profile
European Heart Journal | Academic Accelerator - About the Journal

About

The European Heart Journal is an international, English language, peer-reviewed journal dealing with cardiovascular medicine. It is an official journal of the European Society of Cardiology and is published weekly.The European Heart Journal aims to publish the highest quality material, both clinical and scientific, on all aspects of cardiovascular medicine. It includes articles related to research findings, technical evaluations, and reviews. In addition it provides a forum for the exchange of information on all aspects of cardiovascular medicine, including education issues.In addition to publishing original papers on all aspects of cardiovascular medicine and surgery, the journal also features reviews, clinical perspectives, ESC Guidelines, and editorial articles about recent developments in cardiology as well as encouraging correspondence from its readers. The European Heart Journal is a peer-reviewed medical journal of cardiology published by Oxford University Press on a weekly basis, on behalf of the European Society of Cardiology. The first issue was published in February 1980.

ISSN
0195-668X
ISSN

The ISSN of European Heart Journal is 0195-668X . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1522-9645
ISSN (Online)

The ISSN (Online) of European Heart Journal is 1522-9645 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Oxford University Press
Publisher

European Heart Journal is published by Oxford University Press .

Publication Frequency
Semimonthly
Publication Frequency

European Heart Journal publishes reports Semimonthly .

Coverage
1980 - Present
Coverage

The Publication History of European Heart Journal covers 1980 - Present .

Open Access
NO
Open Access

European Heart Journal is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Review
Publication Fee

There is no publication fee for submiting manuscript to European Heart Journal. European Heart Journal is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of European Heart Journal is English .

Country/Region
United Kingdom
Country/Region

The publisher of European Heart Journal is Oxford University Press , which locates in United Kingdom .

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

European Heart Journal | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The European Heart Journal Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the European Heart Journal during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of European Heart Journal.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Selected Articles

Full Title Authors
Full Title Authors
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies - 2018 Philippe Charron · Perry M. Elliott · Juan Ramón Gimeno · Alida L.P. Caforio · Juan Pablo Kaski · Luigi Tavazzi · Michal Tendera · Carole Maupain · Cécile Laroche · Pawel Rubis · Ruxandra Jurcut · Leonardo Calò · Tiina Heliö · Gianfranco Sinagra · Marija Zdravkovic · Aušra Kavoliūnienė · Stephan B. Felix · Jacek Grzybowski · Maria-Angela Losi · Folkert W. Asselbergs · José Manuel García-Pinilla · Joel Salazar-Mendiguchía · Katarzyna Mizia-Stec · Aldo P. Maggioni · Aris Anastasakis · Elena Biagini · Zofia T. Bilińska · Francisco Jose Castro · Jelena Celutkiene · Natalija Chakova
P1743Hyperglycemia treatment in patients with acute heart diseases: is it possible to reset the risk of hypoglicemia? - 2018 Deborah Cosmi · B. Mariottoni · Franco Cosmi
Sudden death in patients with Ebstein anomaly - 2018 Christine H. Attenhofer Jost · Nicholas Y. Tan · Abdalla Hassan · Emily R. Vargas · David O. Hodge · Joseph A. Dearani · Heidi M. Connolly · Samuel J. Asirvatham · Christopher J. McLeod
P4588Echo guided septal radiofrequency ablation for treatment of obstructive hypertrophic cardiomiopathy - Case series - 2018 Bruno Pereira Valdigem · E B Correa · Dalmo Antonio Ribeiro Moreira · R B Andalaft · I B Masciarelli Pinto · Alexandre Abizaid · Manuel Cano · L V Armaganijan · T A Paladino Filho · O Verissimo · David LeBihan · Fausto Feres · João Henrique Zucco Viesi · C Nigro Neto · Rodrigo B. Barreto
P2914Clinical scores can infer risk of VT induction in Chagas disease patients - 2018 Bruno Pereira Valdigem · R B Andalaft · Diana Moreira · L R Faria · F G Oliveira · D A Pimenta · E V B Ribeiro · I M Sa Junior · Luciana Armaganijan · Ricardo Garbe Habib · C F Da Silva
4058Effects of selective and nonselective beta-blockers on platelet aggregation in patients with acute coronary syndrome: the PLATE-BLOCK study - 2018 Federica Ilardi · Giuseppe Gargiulo · Gabriele Giacomo Schiattarella · Giuseppe Giugliano · Roberta Paolillo · Giovanni Menafra · E De Angelis · Anna Franzone · Eugenio Stabile · Cinzia Perrino · Plinio Cirillo · Carmine Morisco · Raffaele Izzo · Valentina Trimarco · Giovanni Esposito
3381Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes - 2018 Deborah Cosmi · Li Shen · Michela Magnoli · W T Abrahm · Inder S. Anand · John G.F. Cleland · Jay N. Cohn · G De Berardis · Aldo P. Maggioni · Serge Masson · Antonio Nicolucci · Lidia Staszewsky · Gianni Tognoni · Franco Cosmi · Roberto Latini
P3574Distal left main trifurcation treatment with dedicated bifurcation stents: subgroup analysis from randomized clinical trials POLBOS I and POLBOS II - 2018 Robert J. Gil · Jacek Bil · Adam Kern · L A Inigo-Garcia · Radoslaw Formuszewicz · Sławomir Dobrzycki · Dobrin Vassilev
P5526First-in-man study of the dedicated bifurcation cobalt-chromium sirolimus-eluting stent: 9-month interim results - 2018 Robert J. Gil · Jacek Bil · Adam Kern · Tomasz Pawłowski
P4717Can we predict what determines prognosis in patients disqualified from heart transplantation - 2018 P Polaska · G Jerzak-Wodzynska · P. Leszek · W Smigielski · J Gajda · Piotr Rozentryt · Jerzy Korewicki · T. Zielinski · T. Rywik
P589Prognostic value of systemic immune-inflammation index in patients with chronic heart failure - 2018 M Seo · T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · I Ikeda · E Fukuhara · J Nakamura · M Abe · M Fukunami
4937Prognostic value of serum cholinesterase in patients with acute decompensated heart failure: a prospective comparative study with other nutritional indexes - 2018 M Seo · T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · I Ikeda · E Fukuhara · J Nakamura · M Abe · M Fukunami
P4748Prognostic value of Fibrosis-4 index in patients admitted for acute decompensated heart failure with reduced or preserved LVEF: a comparative study with nonalcoholic fatty liver disease fibrosis score - 2018 M Kawahira · T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuti · T Kawai · M Seo · I Ikeda · E Fukuhara · M Makoto · J Nakamura · M Fukunami
P4743The prognostic impact of worsening and improved renal function in acute decompensated heart failure with and without reduced left ventricular ejection fraction - 2018 T Kawai · T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · M Seo · M Fukunami
P4745Long-term prognostic value of cardiorenohepatic syndrome in patients admitted for acute decompensated heart failure - 2018 T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · M Seo · J Nakamura · M Abe · K Kayama · M Kawahira · K Tanabe · M Fukunami
P5358Prognostic impact of cardiac MIBG imaging in heart failure with reduced, mid-range and preserved left ventricular ejection fraction admitted for acute decompensated heart failure - 2018 M Seo · T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · I Ikeda · E Fukuhara · J Nakamura · M Abe · M Fukunami
P918Prognostic value of the combination of plasma volume status and acute kidney injury in acute decompensated heart failure patients with preserved left ventricular ejection fraction - 2018 T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · M Seo · J Nakamura · M Abe · K Kayama · M Kawahira · K Tanabe · M Fukunami
P4747Long-term prognostic value of the serial change of pulse pressure during hospitalization in patients admitted for acute decompensated heart failure - 2018 T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · M Seo · J Nakamura · M Abe · K Kayama · M Kawahira · K Tanabe · M Fukunami
P1021Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction - 2018 M Kawasaki · T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · A Kikuchi · T Kawai · M Seo · I Ikeda · E Fukuhara · M Abe · J Nakamura · M Fukunami
P922Model of end-stage liver disease excluding INR score provides additional prognostic information to the get with the guidelines-heart failure risk score in acute decompensated heart failure patients - 2018 T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · M Seo · J Nakamura · M Abe · K Kayama · M Kawahira · K Tanabe · M Fukunami
4942Serum cholinesterase level provides the additional long-time prognostic information to AHEAD risk score in patients with acute decompensated heart failure - 2018 M Seo · T Yamada · T Morita · Y Furukawa · Shunsuke Tamaki · Y Iwasaki · M Kawasaki · A Kikuchi · T Kawai · I Ikeda · E Fukuhara · J Nakamura · M Abe · M Fukunami